Cargando…
Combinatorial Antitumor Activity of Oxaliplatin with Epigenetic Modifying Agents, 5-Aza-CdR and FK228, in Human Gastric Cancer Cells
Epigenetic silencing is considered to be a major mechanism for loss of activity in tumor suppressors. Reversal of epigenetic silencing by using inhibitors of DNA methyltransferase (DNMT) or histone deacetylases (HDACs) such as 5-Aza-CdR and FK228 has shown to enhance cytotoxic activities of several...
Autores principales: | Park, Jong Kook, Seo, Jung Seon, Lee, Suk Kyeong, Chan, Kenneth K, Kuh, Hyo-Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254647/ https://www.ncbi.nlm.nih.gov/pubmed/30173503 http://dx.doi.org/10.4062/biomolther.2018.061 |
Ejemplares similares
-
FK228 from Burkholderia thailandensis MSMB43
por: Liu, Xiang-Yang, et al.
Publicado: (2012) -
FK228 Analogues Induce Fetal Hemoglobin in Human Erythroid Progenitors
por: Makala, Levi, et al.
Publicado: (2012) -
The structural basis of an NADP(+)-independent dithiol oxidase in FK228 biosynthesis
por: Li, Jie, et al.
Publicado: (2014) -
FK228 sensitizes radioresistant small cell lung cancer cells to radiation
por: Li, Hong, et al.
Publicado: (2021) -
Mechanistic studies of DepR in regulating FK228 biosynthesis in Chromobacterium violaceum no. 968
por: Qiao, Yongjian, et al.
Publicado: (2018)